Davila Fajardo, Raquel
Mayo Clinic
Department of Radiation Oncology, University Medical Center, Utrecht, the Netherlands.
Citations 2
Local Control of Bladder/Prostate Rhabdomyosarcoma: An Expert Consensus Guideline From the International Soft Tissue Sarcoma Consortium (INSTRuCT)
Buchanan, Amanda F , Fajardo, Raquel Davila, Fuchs, Joerg, Granberg, Candace F. , Martelli, Hélène , Passoni, Niccolò, Perkins, S., Smeulders, Naima , Timmerman, Beate, Routh, Jonathan C., Fajardo, Raquel Dávila , Davila Fajardo, Raquel , Indelicato, Daniel J. , Chargari, Cyrus , Fuchs, Joerg , Routh, Jonathan C.
Pediatric Blood & Cancer | March 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
ABSTRACT The local treatment of bladder and prostate rhabdomyosarcoma is a multidisciplinary decision, incorporating elements of patient age, tumor size and location, nodal involvement, and access to local expertise and technology. The relative absence of long‐term bladder and bowel function outcome data complicates discussions, particularly given improved survival rates and development of new surgical and radiotherapy techniques. These INSTRuCT guidelines, a collaboration of the Children's Oncology Group, Soft Tissue Sarcoma Committee, European Pediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe, reflect international expert consensus and are intended to inform practice, generate discussion, and highlight areas of future inquiry.
Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Scheltinga, Sheila Terwisscha van , Kao, Simon C. , Keizer, Bart de , McCarville, M. Beth , Casey, Dana L. , Merks, Hans, Kapadia, Tejas , Walterhouse, David O., Hiemcke‐Jiwa, Laura S. , Franzius, Christiane, Vokuhl, Christian , Dasgupta, Roshni, Birz, Suzi , Rodeberg, David A. , Dasgupta, Roshni , Terwisscha van Scheltinga, Sheila , de Keizer, Bart , Shulkin, Barry L , Casey, Dana L , Allen-Rhoades, Wendy, Orbach, Daniel , Davila Fajardo, Raquel , Oberoi, Saphna , Vokuhl, Christian , Rodeberg, David A , Kao, Simon C , Dasgupta, Roshni , Schoot, Reineke A , Routh, Jonathan C. , Seitz, Guido , Shulkin, Barry L. , Ewijk, Roelof van , Allen‐Rhoades, Wendy , Mercolini, Federico , Merks, Hans, Fajardo, Raquel Dávila , Corti, Federica De , Tang, Vivian , Metts, Jonathan L.
Pediatric Blood & Cancer | January 23, 2025 | Volume: 72 | Issue: 4 | Pages: No page available
ABSTRACTAccurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node staging strategies, definitions, and treatment protocols between the Children's Oncology Group (COG), European paediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS) complicate comparisons. In this article, we aim to establish internationally recognized recommendations for lymph node assessment and treatment of children and adolescents diagnosed with rhabdomyosarcoma (RMS) and non‐rhabdomyosarcoma soft tissue sarcoma (NRSTS) according to the Consensus Conference Standard Operating Procedure methodology.